CAR intergenic 10 (CAR10) a novel lncRNA, could bind and stabilize transcription factor Y-box-binding protein 1 (YB-1), leading to up-regulation of the epidermal growth factor receptor (EGFR) and proliferation of lung cancer cells, and CAR10-YB-1 represented a potential therapeutic target in NSCLC[11]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.